Pharmacy Podcast Network

Digital Transformation of the Mobile Connected Pharmacy | Rx Delivered Now

Apps are now an integral part of our daily micro-moments, with people spending an average of 30 hours per month in them, according to Nielsen
Although these seem like big tech corporations, they enabled smaller businesses to a degree. For instance, local restaurants that would’ve normally closed during the pandemic due to dining restrictions became dependent on delivery clients.
People have mixed feelings about these tech apps - on the one hand, they want to support local community businesses by going to them directly, but on the other hand, they are dependent on these apps to facilitate their life. 
Mobile technology has been crucial to every industry, as mobile phones are the first and last tangible step in peoples’ routines. Families are more likely to get a phone before a computer for the household - so mobile optimization has to be up to the standard usability of a desktop.
Our guests: 
Dr. Anthony Do PharmD is a Pharmacist, with over a decade in experience working in practice at Kaiser, software engineer and is now CEO and founder of Rx Delivered Now. He earned his doctoral from Western University college of Pharmacy where he was also president of the NCPA chapter.
Dr. Ken Thai PharmD co-founded 986 Pharmacy in July 2014. He is the CEO and serves on its Board of Directors. Dr. Thai earned his Doctoral from USC School of Pharmacy and went on to complete his residency in community pharmacy practice
Learn more about your ad choices. Visit megaphone.fm/adchoices

Diabetes Management and Education in the Severely Mentally Ill Population | Beyond the Sig

On today's episode, we welcome Ryan Ray, PharmD, a clinical pharmacist and Certified Diabetes Care and Education Specialist for Wellpower. As a staff pharmacist, Dr. Ray's responsibility is to collaborate with other mental health staff providers to help his patients manage their diabetes and help understand the long term complications of poor diabetes control. In addition to his staff pharmacy role, he is also integrated into diabetes care and education into WellPower's integrated Primary Care Unit. Dr. Ray is focused on addressing health inequities he has identified over his years of experience with the SMI population. This work includes creating a new curriculum to teach DSMES to the SMI population and using and advocating for advanced technology to be incorporated into his practice and diabetes practice as a whole. Join us as we discuss the successes and challenges with the SMI population and how to overcome some barriers!
Learn more about your ad choices. Visit megaphone.fm/adchoices

LTC Pharmacy – Understanding the Changing Landscape | Integra X-Files

Alan Rosenbloom, founder of the Senior Care Pharmacy Coalition (SCPC), joins 
Frances Nahas, Chief Strategy Officer at RedSail Technologies, and Jim McDonald, 
Vice President of Sales, for a candid discussion on the shifting landscape of long-term 
care and how pharmacies can stay abreast of the policies that will create a myriad of 
opportunities and challenges in how care is accessed and provided.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Greg Dewey on Retirement, Accomplishments, and Social Entrepreneurship

During his eight-year tenure at Albany College of Pharmacy and Health Sciences, Dr. Greg Dewey accomplished many great things. In this episode of Occupation Station Dr. Dewey reflects on The Collaboratory, the Stack Family Center for Biopharmaceutical Education and Training (CBET), and the creation of two student-run pharmacies.  
 
The Collaboratory, a “laboratory for collaboration,” offers services which are delivered to residents in Albany by ACPHS’s Public Health Pharmacy Team and Trinity Alliance’s Wellness Advocates Linking Communities (WALC) team. Programs at The Collaboratory address social justice and social determinants of health with the shared goal of improving population health. CBET is an evolutionary leap in health sciences education and biomanufacturing workforce training. Dr. Dewey is perhaps most proud of the creation of two student-run pharmacies both situated in what would be deemed “pharmacy deserts.” The pharmacies, which are located in Albany and Schenectady, N.Y., are prime examples of social entrepreneurship and are designed to have a lasting impact on the communities they serve, while also helping to develop skills that students will benefit from. Dr. Dewey explains that social entrepreneurship involves being self-sustaining while doing public good.   
 
Because of his relationships with faculty, staff, and students, coupled with the development of these crucial initiatives, Dr. Dewey has found his work at ACPHS to be greatly gratifying. And because of his enormous contributions at ACPHS he will be greatly missed!
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacists Impact on Biosimilar Adoption with special guest Sonia Oskouei, PharmD

As an innovative method to improve the affordability of costly biological therapies, there's new medication products being developed with the needed approval of the Food and Drug Administration (FDA) for biological products that are “highly similar” (biosimilar) to or interchangeable with traditional drug developed products. Biosimilars are not completely identical to the innovator product because of the large molecular size, complexity and proprietary nature of the manufacturing process, and inherent variability of all biopharmaceuticals.
Dr. Sonia Oskouei, PharmD, BCMAS, DPLA is Vice President of Biosimilars at Cardinal Health. Sonia shares her experiences in the biosimilars sector of drug development and shares how we're entering these new therapeutic areas, with ophthalmology being the latest focus. Sonia explains how we need more information to help build clinical confidence in these agents. So, any type of data or evidence in understanding of the FDA approval pathway and the associated scientific rigor from the FDA is key to helping build clinical confidence.
"Pharmacists are becoming more and more involved in the care team, particularly in oncology and in the health system setting. So, pharmacists often are partnering or leading with physicians to champion the education process associated with biosimilars, and that's multistakeholder education, both physicians, other pure pharmacists, and supporting patients and their journey.
Pharmacists are also strong contributors to biosimilar adoption and management, particularly in the health system setting as a lead often for formulary decisions, P&T committee involvement, where they're looking not only at the clinical considerations of biosimilars but incorporating the economic and even operational considerations associated with these products, so understanding the complete picture and how best to optimize and leverage biosimilars within their institutions."
Learn more about your ad choices. Visit megaphone.fm/adchoices

Postpartum Sexual Health | Sex PharmD

Daisy Bravo is an online pregnancy & postpartum fitness coach and the founder of Strong Moms Fitness. Her passion for health and fitness has led her to a 20-year career supporting moms to reach their health and fitness goals. 
Early on in her personal training career, she noticed that many trainers in the gym did not know what to do with pregnant women and new mothers. She identified two types of trainers; the ones that we’re afraid to work with moms and the ones that either ignored or were unaware that these women needed special consideration. 
Sick of seeing this population ignored in standard fitness programs, and also wanting for herself to have a fit pregnancy. Daisy spent years learning how to help herself and other women have an empowered pregnancy. It wasn’t long into her studies that Daisy realized it was her destiny to work with pregnant and postpartum women and continue to raise awareness that women can be a badass in the gym…even if they are pregnant or a new mom.
Daisy’s mission is to support moms who feel pressure from society to quickly lose weight after baby.  In their effort to look good on the outside it is so common to see moms resume pre-baby activities only to find themselves injured and left to accept that things like diastasis, prolapse, and leakage are normal.
Through Daisy’s coaching programs she supports, empowers, and educates women on how to workout safely during pregnancy and then recover and return to exercise after giving birth, without risking injury and avoiding those crash diets.
Social Media -  WEBSITE | INSTAGRAM | FACEBOOK GROUP | PINTEREST | YOUTUBE
Podcast - https://www.strongmomsfitnesspodcast.com/
Book - http://flatabsafterbaby.com/ use coupon code PHARMACIST for 20% off
Media Kit with Bio & Images -  Daisy Bravo Media Kit - Strong Moms Fitness
Learn more about your ad choices. Visit megaphone.fm/adchoices

Uncovering The First Year of Medical School with Dr. Tim Do | The Physician Pharmacist Podcast

Have you ever considered a career in medicine after pharmacy? Join us today to explore what the first year of medical school is like and how it compares to pharmacy! In today’s show, we will cover topics related to application logistics, basic MCAT principles, application timing, applying to pharmacy residencies, tackling pharmacy boards, adjusting to the medical school life, and reflections on a career in medicine!
Links:
1. Medical School Application Platform; AMCAS - https://students-residents.aamc.org/
2. American Association of Colleges of Osteopathic Medicine (AACOM): - https://www.aacom.org/
3. Medical School Acceptance Rates By Major in 2022 (BeMo) - https://bemoacademicconsulting.com/blog/medical-school-acceptance-rates-by-major
Learn more about your ad choices. Visit megaphone.fm/adchoices

Congressman Buddy Carter and General Counsel of NCPA Matthew Seiler on PBM Reform

Congressman Buddy Carter and General Counsel of NCPA Matthew Seiler on PBM Reform. On this episode of the 'PBM Reform Podcast' we discuss the Pharmacy Benefit Manager (PBM) Transparency Act of 2022 (the Act) was recently proposed in the U.S. Senate and intends to incentivize “fair and transparent” PBM practices, prohibit spread pricing and claw backs of payments to pharmacies, and empower the Federal Trade Commission (FTC) and state attorneys general in enforcement actions to stop “unfair and deceptive” PBM business practices.
The Act was introduced by Senators Maria Cantwell Chuck Grassley on May 24, 2022, and was approved by the Commerce Committee with bipartisan support (19-9) on June 22, 2022. This summary provides a high-level overview of the Act’s key measures.
Prohibition on Unfair or Deceptive Prescription Drug Pricing Practices
The Act would make it illegal for PBMs to:
Engage in “spread pricing,” which is described as charging a health plan or payer a different amount for a prescription drug’s ingredient cost or dispensing fee than the amount the PBM reimburses a pharmacy for the prescription drug’s ingredient cost or dispensing fee where the PBM retains the amount of any such difference;
Arbitrarily, unfairly, or deceptively reduce or rescind (a.k.a. “claw back”) any portion of the reimbursement payment to a pharmacist or pharmacy for a prescription drug’s ingredient cost of dispensing fee; or
Arbitrarily, unfairly, or deceptively increase or lower fees and reimbursements to a pharmacy to offset reimbursement changes under any federally funded health plan.
The Act would incentivize transparency by stating that a PBM shall not be in violation of the Act if the PBM passes through 100% of price concessions to a health plan or payer and provides complete disclosure of:
The cost, price, and reimbursement of prescription drugs to each health plan, payer, and pharmacy;
All fees, markups, and discounts the PBM charges or imposes on each health plan, payer, and pharmacy; and
The aggregate remuneration PBM receives from drug manufacturers, including nay rebate, discount, administration fee, and any other payment or credit obtained or retained by PBM.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacists Leading in Public Health | Pharmacy Podcast Nation

Dr. Jennifer N. Lind, PharmD, MPH, MBA
Jennifer N. Lind, PharmD, MPH, MBA, is a Pharmacist and Epidemiologist in CDC’s Medication Safety Program and a Commander in the United States Public Health Service Commissioned Corps. CDR Lind received her Doctor of Pharmacy degree from Florida A&M University in 2007, Master of Public Health from Georgia State University in 2012, and Master of Business Administration from Emory University in May 2022. After receiving her MPH, she completed a two-year fellowship as an Epidemic Intelligence Service (EIS) officer in CDC’s National Center for Chronic Disease Prevention and Health Promotion, conducting research and surveillance related to infant and young child feeding practices. 
Following EIS, she worked in CDC’s Birth Defects Branch and eventually became the Lead Scientist for CDC’s Treating for Two initiative, focused on safer medication use in pregnancy. CDR Lind’s current work in CDC’s Medication Safety Program focuses on reducing harms from the use of medications and she serves as Lead Pharmacist for the PROTECT initiative, an innovative public-private partnership that uses a collaborative, data-driven approach to reduce harms from unintentional medication overdoses in children. CDR Lind has also been a leader in multiple emergency responses, including COVID-19.
 
During her 15 years of experience, CDR Lind has authored/co-authored 35 publications, presented at national and international conferences, and has been interviewed/featured by numerous media outlets, including the national radio show “Top of Mind with Julie Rose,” USA Today, Consumer Reports, CNN, The Doctors Channel, and HealthDay News.
For more information regarding CDC’s Medication Safety Program, the PRevention of Overdoses and Treatment Errors in Children Taskforce (PROTECT) Initiative, and Up & Away, please visit: www.cdc.gov/medicationsafety  
For the most up-to-date information regarding COVID-19 vaccination, please visit: www.cdc.gov/vaccines/covid-19
To learn more about the United States Public Health Service Commissioned Corps, please visit: www.usphs.gov
To learn more about the Epidemic Intelligence Service (EIS) program, please visit: www.cdc.gov/eis  
Learn more about your ad choices. Visit megaphone.fm/adchoices

I Don’t Lichen It, I Love It! | Holistic Journal Club with Susan Egbert | Holistic Pharmacy Podcast

Join host Jenna Carmichael, PharmD for a discussion on Antimycobacterial activity of acetone extract and isolated metabolites from folklore medicinal lichen Usnea laevis Nyl. against drug-sensitive and multidrug-resistant tuberculosis strains with guest Susan Egbert, PharmD. 
Susan (she/her) completed her PharmD at the University of Louisiana at Monroe (ULM). During school, she realized that there's still not a lot done on natural products despite a fair number of drugs having natural origins. Currently, Susan is a third year PhD candidate in chemistry at the University of Manitoba (U of M). Her research is focusing on lichens, biosynthesis of their secondary metabolites, and their pharmacological activity.
Article link: https://pubmed.ncbi.nlm.nih.gov/34536516/ 
How to get in touch with Susan:
Email: sbegbert80@gmail.com 
Twitter: @lichenlady94
Instagram: @lichenlady94
Dr. Jenna Carmichael of Wobbly Arrow Wellness is a holistic oncology pharmacist and health coach. She works with women on the cancer journey looking for a different perspective on wellness. She combines her knowledge in the oncology space along with holistic healing methods of meditation, reiki, and yoga to help empower her clients to choose the path that works the best for their goals. She also offers genetic testing services to get a true, personalized idea of how her clients process their medications for safe and effective therapy. Go to www.wobblyarrowwellness.com for more information on her services.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Navigating the Patient Journey in Specialty Pharmacy- From Evaluation Through Treatment | NASP

Podcast Participants: Mike Baldzicki (AscellaHealth), Randy Falkenrath (President, Onco360), Justin Manning, PharmD (Group Vice President, Business Development, Vivid Clear Rx)
Summary: The specialty pharmacy patient journey is a process, and it starts at the point of care with patient and prescriber, and it goes all the way through the treatment of therapy. Specialty Pharmacy is defined as the service created to manage the handling and service requirements of specialty pharmaceuticals, including dispensing, distribution, reimbursement, case-management and other services specific to patients with rare and/or chronic diseases. There are a lot of extra steps in dispensing a specialty medication, so there's a lot of work to be done by pharmacists and care coordination teams before the specialty drug is given to the patient. Obviously, there’s a higher cost, and so it takes more personnel and systems, so there is more patient coordination needed prior to the pharmacy to dispense that specialty medication. The value of the specialty pharmacist in helping patients to access treatment, adhere to treatment, and really get the best possible outcome of treatment really cannot be overstressed as specialty pharmacist are often responsible for selecting the most appropriate therapy based on the patient's clinical and financial profile or reviewing that prescribed medication to ensure access for the patient. The Specialty Pharmacy Care Teams provide significant mentoring to patients to ensure not only safety but also effectiveness and being proactive and changing therapy so that patients are really getting the best possible benefit or changing to a different medication that may give them a better effect. The specialty pharmacists are an anchor during therapy that they can rely on to make sure that they are helping them deal with complex, challenging, and sometimes lifelong therapies as the specialty care teams play an important role in the patient care journey.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Continuing the Conversation | Optimizing Care for Patients With Endometrial Cancer: A Focus on Pharmacist Interventions and Mitigation of Health Equit...

·      Recognize the role of biomarker expression in the selection of most appropriate treatment options for patients with endometrial cancer
·      Review strategies for identification and management of drug-related toxicities in patients receiving therapy with immune checkpoint inhibitors, targeted agents, or combination therapy
Faculty:
Sarah Hayward, PharmD, BCOP
Clinical Pharmacy Specialist, Gynecologic Oncology
Stephenson Cancer Center at OU Health
University of Oklahoma Health Science Center
Oklahoma City, Oklahoma
Sarah Hayward, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Consultant (advisory board): GSK, Seagen/Genmab
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-322-H01-P. The activity is available for CE credit through June 30, 2023.
This educational activity is supported by an educational grant from GlaxoSmithKline
Learn more about your ad choices. Visit megaphone.fm/adchoices

Understanding Chronic Lymphocytic Leukemia Drug Therapies | PTCE Pharmacy Connect

The use of oral therapies for chronic lymphocytic leukemia has had a great impact on patient outcomes and quality of life. Pharmacists can play a key role in assisting with therapy selection, education for patients and the healthcare team, and also managing adverse effects for patients receiving these therapies.
Objectives
Differentiate novel therapies for the treatment of chronic lymphocytic leukemia (CLL) by pharmacologic properties and special considerations for use
Associate drug therapy and safety and efficacy information with treatment selection for patients with CLL
Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida.
Dr. Tobon has no relevant financial relationships with commercial interests to disclose.
Accreditation and support statement: 
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Administered by Janssen Scientific Affairs, LLC and BeiGene, Ltd.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Role of JAK Inhibitors in the Management of Atopic Dermatitis

This podcast will specifically focus on clinical safety and efficacy data supporting the use of new and emerging JAK inhibitors in the management of AD. Practical counseling points for pharmacists to provide individualized care and proper selection of therapy to patients with AD who are initiating therapy with JAK inhibitors will also be discussed. Faculty experts will review audience questions and identify best practices in the management of AD.
o  The Role of JAK Inhibitors in the Management of Atopic Dermatitis: Latest Advances and Best Practices for the Pharmacist
o  Introduction of faculty, affiliations, and disclosures
We would like to thank Sarah Lant, PharmD for her contribution in developing the content for this podcast.
Lana Gerzenshtein, PharmD and Sarah Lant have no relevant financial relationships with commercial interests to disclose.
o  Accreditation and support statement
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
This activity is supported by educational grants from Incyte.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Chronic Lymphocytic Leukemia: Insights into the Pharmacist Role in Therapy Management | PTCE Pharmacy Connect

Introduction of faculty and disclosures: 
Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida.
Dr. Tobon has no relevant financial relationships with commercial interests to disclose.
Accreditation and support statement: 
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Administered by Janssen Scientific Affairs, LLC and BeiGene, Ltd.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Integrating CGM into Diabetes Education | Beyond the Sig

Join us today as we talk all things continuous glucose monitoring with a diabetes care and education specialist, Dr. Diana Isaacs. Learn more about the barriers and challenges associated with using CGM for your patients and strategies to overcome these challenges. In addition, Dr. Diana Isaacs walks us through the newest technologies and innovations in the diabetes management space as diabetes care has transformed drastically in the last decade.  
Learn more about your ad choices. Visit megaphone.fm/adchoices

Advocating for Health Equity w/Dr. Stephanie Young Moss | Holistic Pharmacy Podcast

Today I want to highlight the work of another pharmacy and entrepreneur colleague, Dr. Stephanie Young Moss (aka “Yomo”). She caught my eye on Instagram, where she shines her light on wellness, family dynamics, pharmacy practice, and disparities in healthcare. A practical tip that she shared in the episode has stuck with me, about how learning goes both ways. For example, shadowing allows healthcare students to learn from professionals, but the mentors also get the opportunity to learn. A relationship with someone different than you helps you understand where they’re coming from and how you can serve different populations.
Dr. Stephanie received her Doctor of Pharmacy degree from Xavier University of Louisiana College of Pharmacy and a Masters of Health Services Administration with a concentration in Health Economics from The University of Wyoming. She has worked in various areas in pharmacy, Community, Regulatory Compliance, Managed Care, and Health Economics and Outcomes Research.
Over the past 20 years Dr. Moss has advocated for decreasing disparities in health care through her volunteer work. She uses her platform to educate families across the U.S. on ways to decrease and eliminate health disparities by incorporating simple wellness and mental health techniques. Dr. Moss has shared her views on international and national podcasts and local television news stations.
Dr. Stephanie is the creator of the website www.drstephanieyomo.com where you will find practical health and wellness tips, ways to reduce healthcare disparities and simple tips for health and wellness professionals to enhance their presence on social media so they can stand out in their niche, build a successful brand and advocate for important causes.
She is also the owner of Integrative Pharmacy Outcomes and Consulting, which focuses on educating underserved communities on ways to reduce and prevent health disparities.
For nearly 2 decades, Dr. Stephanie has served on various boards and volunteer organizations that focus on health equity, decreasing implicit bias, addressing social determinants of health and empowering communities to advocate for their health. She has served on the boards for The Minority Health Coalition of Marion County and Eskenazi Health Center where she has served as the Clinical Quality Committee Chair, Board Secretary and is currently the Board Treasurer. She resides in Indianapolis, Indiana.
You can connect with Dr. Yomo on all social media (@Dr. Stephanie Yomo) and www.drstephanieyomo.com.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Finance and the Pharmacy Owner: A Conversation With David George | Pharmacy Insiders

Please join the discussion with David George from Total Dose Pharmacy and First Financial Loan Officer, Drew Hegi from First Financial Bank. 
David George is one of the founders of Total Dose Pharmacy that was established in 2013. He began the startup in Oklahoma and subsequently a second store, Hutton Pharmacy. 
Total Dose aims to be embedded as a healthcare cornerstone of every community in which they are located. They strive to be innovative in the services and products they offer, as well as experts in provision of care and education to patients. Ultimately, their goal is to be the pharmacy franchise where patients want to receive healthcare and people want to work.
Drew Hegi, has been a Loan Officer at FFB since 2012. Drew is also an Independent Pharmacy owner. Drew enjoys coaching buyers through the details of pharmacy ownership. Clear communication helps alleviate concerns, and he understands the necessary skills and tools needed to navigate the process.
Learn more about your ad choices. Visit megaphone.fm/adchoices

RxSummit 2022 Conference Summary | PAIN POD

https://www.rx-summit.com/
Dr. Mark Garofoli was live and in person at the 2022 RxSummit Conference which hosted anyone and everyone affiliated with and touched by our country's Drug Crisis. The "Pain Guy" spoke with many federal and state leaders (including our U.S. Drug Czar Dr. Gupta, our NIDA Director Dr. Volkow, DEA leadership, and so on), along with fellow conference presenters and attendees alike. Many of those conversations were recorded and contained within this dynamic conference summary episode of the Pain Pod!
Learn more about your ad choices. Visit megaphone.fm/adchoices

What’s the Impact of the Pharmacy Benefit Manager Transparency Act of 2022

Senator Chuck Grassley (R-Iowa) and Maria Cantwell (D-Wash.) introduced the Pharmacy Benefit Manager Transparency Act of 2022 on May 24, which would make it illegal for PBMs to engage in “spread pricing.” Spread pricing occurs when PBMs charge health plans and payers more for a prescription drug than what they reimburse to the pharmacy — and then keep the difference. For example, when a pharmacist fills a prescription, a PBM handles the process, informing the pharmacy it will be reimbursed $90. 
The PBM then charges the health insurance plan $100 for processing the same prescription. The spread of $10 is pocketed by the PBMs. Related: New PBM players banking on drug pricing transparency for success The bipartisan legislation would empower the Federal Trade Commission (FTC) to increase drug pricing transparency and hold pharmacy benefit managers (PBMs) accountable for unfair and deceptive practices that drive up the costs of prescription drugs at the expense of consumers. 
It also would prohibit arbitrary clawbacks of payments made to pharmacies and require PBMs to report to the FTC how much money they make through spread pricing and pharmacy fees.
SCPC, CEO, Alan Rosenbloom & Senior Director, Regulatory Policy at APhA, Michael Baxter join Todd Eury with the Pharmacy Podcast Network to discuss the impact of the Pharmacy Benefit Manager Transparency Act of 2022 on the Pharmacy Profession.
Learn more about your ad choices. Visit megaphone.fm/adchoices